O2–11–02: PET radioligand binding to translocator protein may mark conversion from mild cognitive impairment to Alzheimer's disease

O2-11-02 PET RADIOLIGAND BINDING TO TRANSLOCATOR PROTEIN MAY MARK CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER’S DISEASE William Kreisl, Chul Hyoung Lyoo, Meghan McGwier, Joseph Snow, Kimberly Jenko, Nobuyo Kimura, Winston Corona, Cheryl Morse, Sami Zoghbi, Victor Pike, Francis McMahon, Raymond Turner, Robert Innis THE FOUNDATION FOR NIH BIOMARKERS CONSORTIUM PET RADIOLIGAND PROJECT TEAM,National Institute of Mental Health, Bethesda, Maryland, United States; Georgetown University, Washington, D.C. United States; Foundation for the National Institutes of Health, Bethesda, Maryland, United States. Contact e-mail: kreislw@mail.nih.gov